Early Stage Venture Sonoma BioTherapeutics Raises Series A of $30000000

September 29, 2020

About Sonoma BioTherapeutics

Sonoma BioTherapeutics seattle-based company leading the development of adoptive Treg therapies cell for autoimmune.

Website: Learn more on Sonoma BioTherapeutics’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – Sonoma BioTherapeutics

Amount Raised30000000 USD
Announced Date2020-09-30
Equity Only FundingYes
Organization LocationSouth San Francisco, California, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds2
Lead Investors
Number of Investors8
Number of Partner Investors2